NASDAQ · SERVICES-MISC HEALTH & ALLIED SERVICES, NEC · MID CAP
Viemed Healthcare, Inc. VMD
8 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$270.3M
▲ 20.5% vs FY2024
EPS · FY25
$0.37
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
10.9%
Net margin · FY25
5.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 270.3M
Revenue, FY2025 · full 8-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 0.37
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
10.9%
Return on equity, FY2025
ROE
Operating margin8.5%
Net margin5.5%
Return on assets7.9%
Each USD of equity produced 11 cents of profit this year.
Returned to shareholders
USD 11.8M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 11.8M
Share of profit78.9%
Consecutive raises—
USD 11.8M in buybacks — 79% of the year's profit went back to shareholders.
Growth
+15.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+24.9%
+15.5%
Net income
+33.9%
−13.9%
EPS, diluted
+32.2%
−13.9%
Returned to shareholders
+8.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.04B
Shares outstanding, FY2025
Change, 5 years−3.0%
Change, 10 years—
The share count shrank 3% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 199.2M
total assets, end of FY2025
Total assetsUSD 199.2M
EquityUSD 141.5M
CashUSD 13.5M
Gross debtUSD 12.4M
Net debtUSD -1.1M
Current ratio1.18×
The company holds more cash than debt.
History
8 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
Revenue $B
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
Operating income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
0.0
Net income $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
0.37
0.28
0.25
0.16
0.22
0.78
0.21
0.24
Dividend / sh $
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
ROE %
10.9
9.2
9.7
6.5
10.3
50.3
22.4
29.2
Shares out B
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
32 of 32
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed